42.9% were classified as benign tumors and 57.1% were classified as malignant tumors with 19.8% were soft tissue tumors, 19.8% were GISTs, and 5.4% were malignant peripheral nerve sheet tumors, 9.9% were lymphoma, and only 2.2% were germ cell tumors.